Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
5Y CAGR
+32.0%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $241.65M | +22.9% |
| 2024 | $196.61M | +2.9% |
| 2023 | $191.09M | +232.1% |
| 2022 | $-144.65M | -266.5% |
| 2021 | $86.90M | +44.0% |
| 2020 | $60.34M | +170.9% |
| 2019 | $22.27M | +52.7% |
| 2018 | $14.59M | - |